Study Evaluating Safety of Etanercept in Treatment of Patients With Moderate to Severe Psoriasiswith Etanercept
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
Evaluate (i) safety of etanercept in patients with moderate to severe psoriasis in Spain;
(ii) the incidence of adverse events reported in these patients, and (iii) the role that age
and concomitant therapy might play in the development of adverse reactions.